Everyone is confused by the partial government shutdown. But at FDA, its mission to protect public health must now be balanced with available user fee funding and no new fiscal appropriation, which can cause more confusion as to what is and is not happening at FDA. Hear from former senior FDA officials about shutdown rules, how they have been applied in the past, and what happens as the carryover user fees dwindle.  


Howard Sklamberg, Partner, Akin Gump, and former Deputy Commissioner for Global Regulatory Operations and Policy, FDA
Rebecca Wood, Partner, Sidley Austin LLP, and former Chief Counsel, FDA
Moderated by Amy Comstock Rick, President & CEO, Food and Drug Law Institute

Related Content